|
Wednesday, November 14, 2018
Print Current Session:
 |
|
|
Wednesday
SESSION 31:
NEW DEVELOPMENTS AND ADVANCES IN MEDICAL AND ANTI-ATHEROGENIC TREATMENTS FOR PATIENTS WITH ARTERIAL DISEASE
Location: Grand Ballroom West, 3rd Floor
Moderators:Mehdi H. Shishehbor, DO, MPH, PhD / Geno J. Merli, MD, MACP, FHM, FSVM |
|
| SESSION 31 SCHEDULE | |
| 6:40 AM - 6:45 AM | How Long Should Patients With DVT Be Kept On Anticoagulants: A Review Of The Data |
|
Presenter(s):Geoffrey Barnes, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:46 AM - 6:51 AM | What Are The New AHA Hypertension Guidelines And Why All PAD Patients Should Be Treated According To These Guidelines |
|
Presenter(s):Jeffrey W. Olin, DO Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:52 AM - 6:57 AM | Benefits Of Cilostazol Before And After Peripheral Endovascular Procedures: What Regimen And Dosage Should Be Given Routinely |
|
Presenter(s):Gary M. Ansel, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 6:58 AM - 7:03 AM | What Is Anacetrapib: Do CETP Inhibitors To Reduce LDL Cholesterol (LDL-C) More Than Statins Have A Role In PAD Patients: What About Ezetemibe (Zetia): How Low An LDL-C Should We Try To Get |
|
Presenter(s):Kavita Sharma, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:04 AM - 7:09 AM | PCSK-9 Inhibitors: Highlights For The Vascular Specialist In 2018 |
|
Presenter(s):Pradeep Natarajan, MD, MMSc Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | DEBATE: Statins Are Dangerous Drugs: Lowering LDL-C Does No Good And Is Harmful In Most Patients |
|
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:16 AM - 7:21 AM | DEBATE: Not So: Lowering LDL-C Levels With Statins And PCSK-9 Inhibitors In At Risk Patients With PAD Prevents Cardiovascular Events And Deaths; It Is Safe And Prolongs Life |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:22 AM - 7:27 AM | How Important Is It To Give High Intensity Statins To PAD Patients: How Low Should We Push Their LDL-C, To <50 mg/dL; What About Adding Other Drugs: What About Statins In Older (>80) PAD Patients |
|
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC / Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:28 AM - 7:33 AM | DEBATE: What Did The COMPASS RCT Show: After This Trial, Rivaroxaban Plus Aspirin Should Be Given To All PAD Patients To Lower Their Risk Of Stroke, MI And Death: What Doses |
|
Presenter(s):Jay Giri, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:34 AM - 7:39 AM | DEBATE: Not So Fast: We Still Need To Know More Before Adding Rivaroxaban For PAD Patients |
|
Presenter(s):Brian H. Annex, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 7:40 AM - 7:46 AM | Panel Discussion |
| END OF SESSION 31 | |
| previous | next |